======= IGF2BP3 ======= == Gene Information == * **Official Symbol**: IGF2BP3 * **Official Name**: insulin like growth factor 2 mRNA binding protein 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10643|10643]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00425|O00425]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IGF2BP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IGF2BP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608259|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: RNA-binding factor that may recruit target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to beta- actin/ACTB and MYC transcripts. Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. {ECO:0000269|PubMed:16541107, ECO:0000269|PubMed:23640942}. |RRM 1| |KH 1| |translation regulator activity| |mRNA 5-UTR binding| |mRNA 3-UTR binding| |regulation of cytokine biosynthetic process| |negative regulation of translation| |negative regulation of cellular amide metabolic process| |mRNA transport| |regulation of mRNA stability| |regulation of RNA stability| |nucleic acid transport| |RNA transport| |establishment of RNA localization| |regulation of mRNA catabolic process| |RNA localization| |nucleobase-containing compound transport| |regulation of mRNA metabolic process| |regulation of translation| |translation| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |regulation of cytokine production| |cellular amide metabolic process| |regulation of cellular catabolic process| |regulation of catabolic process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |organonitrogen compound biosynthetic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |nitrogen compound transport| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.78| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.09| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.72| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.1| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|3.3| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.47| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15227 * **Expression level (log2 read counts)**: 6.15 {{:chemogenomics:nalm6 dist.png?nolink |}}